Phase 1 Trial of Panobinostat in Children With Diffuse Intrinsic Pontine Glioma

Trial Profile

Phase 1 Trial of Panobinostat in Children With Diffuse Intrinsic Pontine Glioma

Recruiting
Phase of Trial: Phase I

Latest Information Update: 29 Sep 2017

At a glance

  • Drugs Panobinostat (Primary)
  • Indications Glioma
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 21 Sep 2017 Protocol has been amended to change in the Treatment arm and primary endpoint.
    • 21 Sep 2017 Planned number of patients changed from 20 to 40.
    • 25 Aug 2017 Planned End Date changed from 1 Feb 2019 to 1 Oct 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top